Ipilimumab/nivolumabRenal granulomatous arteritis: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1824卷 / 1期
关键词：
D O I：
10.1007/s40278-020-84136-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：168 / 168
相关论文
共 50 条
  • [1] Ipilimumab/nivolumabRenal side effects: case report
    Reactions Weekly, 2018, 1709 (1) : 130 - 130
  • [2] Ipilimumab-induced renal granulomatous arteritis: a case report
    Mathilde Lemoine
    Baptiste Dilly
    Alexandre Curie
    Vivien Hébert
    Charlotte Laurent
    Mélanie Hanoy
    Steven Grangé
    Dominique Guerrot
    Arnaud François
    Dominique Bertrand
    BMC Nephrology, 20
  • [3] Ipilimumab-induced renal granulomatous arteritis: a case report
    Lemoine, Mathilde
    Dilly, Baptiste
    Curie, Alexandre
    Hebert, Vivien
    Laurent, Charlotte
    Hanoy, Melanie
    Grange, Steven
    Guerrot, Dominique
    Francois, Arnaud
    Bertrand, Dominique
    BMC NEPHROLOGY, 2019, 20 (01)
  • [4] Ipilimumab/nivolumabRenal failure and Takotsubo-cardiomyopathy: case report
    Reactions Weekly, 2019, 1751 (1) : 218 - 218
  • [5] Ipilimumab/nivolumabDiffuse granulomatous panniculitis: case report
    Reactions Weekly, 2018, 1683 (1) : 387 - 387
  • [6] Ipilimumab/pembrolizumabInterstitial granulomatous dermatitis: case report
    Reactions Weekly, 2018, 1726 (1) : 219 - 219
  • [7] Ipilimumab/nivolumabGiant cell arteritis: case report
    Reactions Weekly, 2020, 1802 (1) : 170 - 170
  • [8] NivolumabRenal disorder: case report
    Reactions Weekly, 2021, 1858 (1) : 309 - 309
  • [9] NivolumabRenal toxicity: case report
    Reactions Weekly, 2020, 1809 (1) : 190 - 190
  • [10] Ipilimumab/nivolumabRenal dysfunction, myocarditis and liver dysfunction: 3 case reports
    Reactions Weekly, 2022, 1887 (1) : 398 - 398
12345